216 related articles for article (PubMed ID: 12831586)
21. Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols?
Craft I; Gorgy A; Hill J; Menon D; Podsiadly B
Hum Reprod; 1999 Dec; 14(12):2959-62. PubMed ID: 10601078
[TBL] [Abstract][Full Text] [Related]
22. Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study.
Olivennes F; Fanchin R; Bouchard P; Taïeb J; Selva J; Frydman R
Hum Reprod; 1995 Jun; 10(6):1382-6. PubMed ID: 7593501
[TBL] [Abstract][Full Text] [Related]
23. [Protocol of GNRH antagonist in poor responders in IVF-ET cycles].
Grzechocińska B; Fracki S; Marianowski P; Dworniak T; Bablok L; Marianowski L
Ginekol Pol; 2003 Sep; 74(9):943-8. PubMed ID: 14674149
[TBL] [Abstract][Full Text] [Related]
24. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
[TBL] [Abstract][Full Text] [Related]
25. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
[TBL] [Abstract][Full Text] [Related]
26. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial.
Kyrou D; Kolibianakis EM; Fatemi HM; Tarlatzis BC; Tournaye H; Devroey P
Fertil Steril; 2011 Nov; 96(5):1112-5. PubMed ID: 21924414
[TBL] [Abstract][Full Text] [Related]
27. Antagonist protocol versus clomiphene in unexplained infertility: A randomized controlled study.
Nada AM; ElSetohy KA; Banat MM; Shaheen AF
Taiwan J Obstet Gynecol; 2016 Jun; 55(3):326-30. PubMed ID: 27343309
[TBL] [Abstract][Full Text] [Related]
28. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group.
Hum Reprod; 1998 Nov; 13(11):3023-31. PubMed ID: 9853849
[TBL] [Abstract][Full Text] [Related]
29. High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles.
Kol S; Lightman A; Hillensjo T; Devroey P; Fauser B; Tarlatzis B; Mannaerts B; Itskovitz-Eldor J
Hum Reprod; 1999 Sep; 14(9):2242-4. PubMed ID: 10469687
[TBL] [Abstract][Full Text] [Related]
30. Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction.
Sauer MV; Thornton MH; Schoolcraft W; Frishman GN
Reprod Biomed Online; 2004 Nov; 9(5):487-93. PubMed ID: 15588464
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing premature LH surges: report of two large multicentre, multinational, phase IIIb clinical experiences.
Olivennes F; Diedrich K; Frydman R; Felberbaum RE; Howles CM; ;
Reprod Biomed Online; 2003 Jun; 6(4):432-8. PubMed ID: 12831588
[TBL] [Abstract][Full Text] [Related]
32. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
[TBL] [Abstract][Full Text] [Related]
33. Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization.
Gibreel A; Maheshwari A; Bhattacharya S
Cochrane Database Syst Rev; 2012 Nov; 11():CD008528. PubMed ID: 23152261
[TBL] [Abstract][Full Text] [Related]
34. Gonadotrophin-releasing hormone antagonists for assisted conception.
Al-Inany H; Aboulghar M
Cochrane Database Syst Rev; 2001; (4):CD001750. PubMed ID: 11687120
[TBL] [Abstract][Full Text] [Related]
35. Clomiphene-induced LH surges and cetrorelix.
Engel JB; Felberbaum RE; Eilers W; Polack S; Ortmann O; Diedrich K
Reprod Biomed Online; 2002; 5(2):109-11. PubMed ID: 12419033
[TBL] [Abstract][Full Text] [Related]
36. Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study.
Hwang JL; Seow KM; Lin YH; Huang LW; Hsieh BC; Tsai YL; Wu GJ; Huang SC; Chen CY; Chen PH; Tzeng CR
Hum Reprod; 2004 Sep; 19(9):1993-2000. PubMed ID: 15284212
[TBL] [Abstract][Full Text] [Related]
37. Cetrotide confirmatory trial of cetrorelix/0.25 mg in 26 women undergoing ovarian stimulation with recombinant follicle stimulating hormones for IVF, ICSI and embryo transfer (ET).
Mettler L; Brandenburg K
Clin Exp Obstet Gynecol; 2000; 27(2):103-5. PubMed ID: 10968345
[TBL] [Abstract][Full Text] [Related]
38. The decrease of serum luteinizing hormone level by a gonadotropin-releasing hormone antagonist following the mild IVF stimulation protocol for IVF and its clinical outcome.
Yanaihara A; Yorimitsu T; Motoyama H; Ohara M; Kawamura T
J Assist Reprod Genet; 2008 Apr; 25(4):115-8. PubMed ID: 18368475
[TBL] [Abstract][Full Text] [Related]
39. [Suppression of endogenous LH increase in ovarian stimulation with the GnRH antagonist Cetrorelix].
Diedrich K; Diedrich C; Santos E; Bauer O; Zoll C; al-Hasani S; Reissmann T; Krebs D; Klingmüller D
Geburtshilfe Frauenheilkd; 1994 Apr; 54(4):237-40. PubMed ID: 8013860
[TBL] [Abstract][Full Text] [Related]
40. Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study.
Weigert M; Krischker U; Pöhl M; Poschalko G; Kindermann C; Feichtinger W
Fertil Steril; 2002 Jul; 78(1):34-9. PubMed ID: 12095487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]